Literature DB >> 20367240

Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain.

Susanna L Lamers1, Marco Salemi, Derek C Galligan, Alanna Morris, Rebecca Gray, Gary Fogel, Li Zhao, Michael S McGrath.   

Abstract

The interplay between pathology and human immunodeficiency virus (HIV) expansion in brain tissues has not been thoroughly assessed in the highly active antiretroviral therapy (HAART) era. HIV-associated dementia (HAD) is marked by progressive brain infection due to recruitment and migration of macrophages in brain tissues; however, the cellular and viral events occurring prior to HAD development and death are under debate. In this study, 66 brain tissues from 11 autopsies were analyzed to assess HIV-1 DNA concentration in brain tissues. In most patients without HAD, it was impossible to amplify HIV-1 from brain tissues. Amplifiable DNA was obtained from three cases of patients on HAART who died due to primary pathology other than HAD: (1) cardiovascular disease, a disease associated with HAART therapy; (2) bacterial infections, including Mycobacterium avium complex, rapid occurrence of extreme dementia; and (3) acquired immunodeficiency syndrome (AIDS)-related lymphoma with meningeal involvement. HIV-1 DNA was also amplified from multiple tissues of two HAD patients. Analysis of HIV-1 nef, gp120, and gp41 sequences showed reduced viral evolution within brain tissues for the non-HAD cases relative to patients with clinical and histological HAD. The present study is the first to show a potential correlation between HIV-1 evolutionary patterns in the brain and different neuropathologies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367240      PMCID: PMC2994721          DOI: 10.3109/13550281003735709

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  49 in total

Review 1.  Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus.

Authors:  P Monier; K McKown; M S Bronze
Journal:  Clin Infect Dis       Date:  2000-11-29       Impact factor: 9.079

Review 2.  Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS.

Authors:  Kenneth C Williams; William F Hickey
Journal:  Annu Rev Neurosci       Date:  2002-03-27       Impact factor: 12.449

3.  HIV mediates a productive infection of the brain.

Authors:  C A Wiley; C L Achim; C Christopherson; Y Kidane; S Kwok; E Masliah; J Mellors; L Radhakrishnan; G Wang; V Soontornniyomkij
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

4.  HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998.

Authors:  N Sacktor; R H Lyles; R Skolasky; C Kleeberger; O A Selnes; E N Miller; J T Becker; B Cohen; J C McArthur
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

5.  Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease.

Authors:  D V Havlir; F J Torriani; R D Schrier; J Y Huang; M M Lederman; K A Chervenak; W H Boom
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.

Authors:  J H Stein; M A Klein; J L Bellehumeur; P E McBride; D A Wiebe; J D Otvos; J M Sosman
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

Review 7.  Permissive factors for HIV-1 infection of macrophages.

Authors:  S M Wahl; T Greenwell-Wild; H Hale-Donze; N Moutsopoulos; J M Orenstein
Journal:  J Leukoc Biol       Date:  2000-09       Impact factor: 4.962

8.  CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing.

Authors:  N Sacktor; P M Tarwater; R L Skolasky; J C McArthur; O A Selnes; J Becker; B Cohen; E N Miller
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

9.  Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes.

Authors:  Rachel Williams; Navneet K Dhillon; Sonia T Hegde; Honghong Yao; Fuwang Peng; Shannon Callen; Yahia Chebloune; Randall L Davis; Shilpa J Buch
Journal:  Glia       Date:  2009-05       Impact factor: 7.452

10.  Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

Authors:  K C Williams; S Corey; S V Westmoreland; D Pauley; H Knight; C deBakker; X Alvarez; A A Lackner
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  39 in total

Review 1.  Eradication of human immunodeficiency virus from brain reservoirs.

Authors:  Avindra Nath
Journal:  J Neurovirol       Date:  2014-11-04       Impact factor: 2.643

Review 2.  Update on HIV-associated neurocognitive disorders.

Authors:  Tariq B Alfahad; Avindra Nath
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

3.  Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription.

Authors:  Yaxia Yuan; Xiaoqin Huang; Jun Zhu; Chang-Guo Zhan
Journal:  Future Med Chem       Date:  2016-10-14       Impact factor: 3.808

4.  [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein.

Authors:  Matthew Strauss; Bernadette O'Donovan; Yizhi Ma; Ziyu Xiao; Steven Lin; Michael T Bardo; Pavel I Ortinski; Jay P McLaughlin; Jun Zhu
Journal:  J Pharmacol Exp Ther       Date:  2020-05-27       Impact factor: 4.030

Review 5.  Where does HIV hide? A focus on the central nervous system.

Authors:  Melissa Churchill; Avindra Nath
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

Review 6.  The effects of cocaine on HIV transcription.

Authors:  Mudit Tyagi; Jaime Weber; Michael Bukrinsky; Gary L Simon
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

Review 7.  The meningeal lymphatic system: a route for HIV brain migration?

Authors:  Susanna L Lamers; Rebecca Rose; Lishomwa C Ndhlovu; David J Nolan; Marco Salemi; Ekaterina Maidji; Cheryl A Stoddart; Michael S McGrath
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

8.  HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.

Authors:  Rebecca Rose; Susanna L Lamers; David J Nolan; Ekaterina Maidji; N R Faria; Oliver G Pybus; James J Dollar; Samuel A Maruniak; Andrew C McAvoy; Marco Salemi; Cheryl A Stoddart; Elyse J Singer; Michael S McGrath
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

9.  HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.

Authors:  Susanna L Lamers; Rebecca Rose; Ekaterina Maidji; Melissa Agsalda-Garcia; David J Nolan; Gary B Fogel; Marco Salemi; Debra L Garcia; Paige Bracci; William Yong; Deborah Commins; Jonathan Said; Negar Khanlou; Charles H Hinkin; Miguel Valdes Sueiras; Glenn Mathisen; Suzanne Donovan; Bruce Shiramizu; Cheryl A Stoddart; Michael S McGrath; Elyse J Singer
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

10.  Envelope gene evolution and HIV-1 neuropathogenesis.

Authors:  Fabián J Vázquez-Santiago; Vanessa Rivera-Amill
Journal:  J Neuroinfect Dis       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.